Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
11m
EU regulator backs use of Novo’s Wegovy for obesity-related heart condition
The European Medicines Agency backed the use of Novo Nordisk's popular drug Wegovy to help ease heart failure in people with ...
31m
on MSN
Novo Nordisk stock tumbled over the latest results for its experimental weight loss pill
Ozempic maker Novo Nordisk (NVO) announced mixed results today for a phase 2 trial of an experimental weight loss pill that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Kentucky judge fatally shot
Secret Service probing post
FCC chair denies Trump call
Boy kills bear, saves father
Cancels appearance w/ Duda
Ban called for in TX schools
Families lose appeal
Body found in SUV
To get a second moon
NYC subway joyride arrest
Man charged for threats
Hold campaign event in MI
MS sheriff's office probe
Collapse hazard recall
Recalling 449K+ vehicles
Vows to remain in race
Stein's ballot bid rejected
Raises settlement offer
PGA welcomes LIV players
'Targeted strike' in Beirut
Gun case sentencing delay
$3B for battery projects
Retires after 17 seasons
FTC on privacy controls
To visit US next week
Brazil threatens daily fines
160M euros to Ukraine
COVID, Wuhan market link
Overdose deaths drop in US
Makes MLB history
Related topics
European Union
Novo Nordisk
Ozempic
Heart failure
Amycretin
Feedback